Ouyang T - Search Results

1

Current status of diagnosis and treatment of primary breast cancer in beijing, 2008.

Yuan XM, Wang N, Ouyang T, Yang L, Song MY, Lin BY, Xie YT, Li JF, Pan KF, You WC, Zhang L. Yuan XM, et al. Among authors: ouyang t. Chin J Cancer Res. 2011 Mar;23(1):38-42. doi: 10.1007/s11670-011-0038-y. Chin J Cancer Res. 2011. PMID: 23467615 Free PMC article.

2

[Neoadjuvant chemotherapy for primary breast cancer].

Li JF, Ouyang T, Wang TF, Lin BY. Li JF, et al. Among authors: ouyang t. Zhonghua Zhong Liu Za Zhi. 2004 Aug;26(8):493-5. Zhonghua Zhong Liu Za Zhi. 2004. PMID: 15555342 Chinese.

3

[Exploration of the extent of axillary dissection for patients with node positive primary breast cancer].

Ouyang T, Li JF, Wang TF, Lin BY. Ouyang T, et al. Zhonghua Wai Ke Za Zhi. 2005 Mar 1;43(5):298-300. Zhonghua Wai Ke Za Zhi. 2005. PMID: 15842936 Chinese.

4

[The application of conservative surgery for local advanced and bigger primary breast carcinoma].

Li JF, Ouyang T, Wang TF, Xie YT, Lin BY. Li JF, et al. Among authors: ouyang t. Zhonghua Wai Ke Za Zhi. 2005 Aug 1;43(15):1008-10. Zhonghua Wai Ke Za Zhi. 2005. PMID: 16194361 Chinese.

5

p53 Codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancer.

Xu Y, Yao L, Ouyang T, Li J, Wang T, Fan Z, Lin B, Lu Y, Xie Y. Xu Y, et al. Among authors: ouyang t. Clin Cancer Res. 2005 Oct 15;11(20):7328-33. doi: 10.1158/1078-0432.CCR-05-0507. Clin Cancer Res. 2005. PMID: 16243804

6

Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status.

Xu Y, Yao L, Li H, Ouyang T, Li J, Wang T, Fan Z, Lin B, Lu Y, Larsson O, Xie Y. Xu Y, et al. Among authors: ouyang t. Breast Cancer Res Treat. 2006 May;97(1):49-55. doi: 10.1007/s10549-005-9086-7. Breast Cancer Res Treat. 2006. PMID: 16319978

7

[Clinical study of percutaneous ultrasound-guided or freehand core needle biopsy of primary breast cancer].

Ouyang T, Li JF, Wang TF, Xie YT, Fan ZQ, Lin BY. Ouyang T, et al. Zhonghua Wai Ke Za Zhi. 2005 Dec 1;43(23):1519-21. Zhonghua Wai Ke Za Zhi. 2005. PMID: 16412288 Chinese.

8

[Preliminary study of new imaging agent, 99mTc-Rituximab, for sentinel lymph node biopsy of primary breast cancer].

Li JF, Ouyang T, Wang XJ, Wang TF, Xie YT, Fan ZQ, Lin BH, Yang Z, Lin BY. Li JF, et al. Among authors: ouyang t. Zhonghua Wai Ke Za Zhi. 2006 May 1;44(9):600-2. Zhonghua Wai Ke Za Zhi. 2006. PMID: 16784652 Chinese.

9

The association of CYP2D6 *10 polymorphism with breast cancer risk and clinico-pathologic characteristics in Chinese women.

Li H, Feng L, Xu Y, Yao L, Ouyang T, Li J, Wang T, Fan Z, Lin B, Li J, Xie Y. Li H, et al. Among authors: ouyang t. Acta Oncol. 2006;45(5):597-601. doi: 10.1080/02841860600660803. Acta Oncol. 2006. PMID: 16864175

10

[Preliminary study on a new sentinel lymphoscintigraphy agent 99mTc-Rituximab for breast patient].

Wang XJ, Lin BH, Yang Z, Ouyang T, Li JF, Xu B, Zhang Y, Zhang MY. Wang XJ, et al. Among authors: ouyang t. Zhonghua Zhong Liu Za Zhi. 2006 Mar;28(3):200-3. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 16875605 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

529 results

Search Page

Filters